Literature DB >> 18375832

Mitochondrial dysfunction and redox signaling in atrial tachyarrhythmia.

Alicja Bukowska1, Lorenz Schild, Gerburg Keilhoff, Daniel Hirte, Manfred Neumann, Andreas Gardemann, Klaus Hinrich Neumann, Friedrich-Wilhelm Röhl, Christof Huth, Andreas Goette, Uwe Lendeckel.   

Abstract

Accumulating evidence links calcium-overload and oxidative stress to atrial remodeling during atrial fibrillation (AF). Furthermore, atrial remodeling appears to increase atrial thrombogeneity, characterized by increased expression of adhesion molecules. The aim of this study was to assess mitochondrial dysfunction and oxidative stress-activated signal transduction (nuclear factor-kappaB [NF-kappa B], lectin-like oxidized low-density lipoprotein receptor [LOX-1], intercellular adhesion molecule-1 [ICAM-1], and hemeoxgenase-1 [HO-1]) in atrial tissue during AF. Ex vivo atrial tissue from patients with and without AF and, additionally, rapid pacing of human atrial tissue slices were used to study mitochondrial structure by electron microscopy and mitochondrial respiration. Furthermore, quantitative reverse transcription polymerase chain reaction (RT-PCR), immunoblot analyses, gel-shift assays, and enzyme-linked immunosorbent assay (ELISA) were applied to measure nuclear amounts of NF-kappa B target gene expression. Using ex vivo atrial tissue samples from patients with AF we demonstrated oxidative stress and impaired mitochondrial structure and respiration, which was accompanied by nuclear accumulation of NF-kappa B and elevated expression levels of the adhesion molecule ICAM-1 and the oxidative stress-induced markers HO-1 and LOX-1. All these changes were reproduced by rapid pacing for 24 hours of human atrial tissue slices. Furthermore, the blockade of calcium inward current with verapamil effectively prevented both the mitochondrial changes and the activation of NF-kappa B signaling and target gene expression. The latter appeared also diminished by the antioxidants apocynin and resveratrol (an inhibitor of NF-kappa B), or the angiotensin II receptor type 1 antagonist, olmesartan. This study demonstrates that calcium inward current via L-type calcium channels contributes to oxidative stress and increased expression of oxidative stress markers and adhesion molecules during cardiac tachyarrhythmia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18375832     DOI: 10.3181/0706-RM-155

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  39 in total

Review 1.  Proteostasis and REDOX state in the heart.

Authors:  Elisabeth S Christians; Ivor J Benjamin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-10-14       Impact factor: 4.733

Review 2.  Molecular Basis of Atrial Fibrillation Pathophysiology and Therapy: A Translational Perspective.

Authors:  Stanley Nattel; Jordi Heijman; Liping Zhou; Dobromir Dobrev
Journal:  Circ Res       Date:  2020-06-18       Impact factor: 17.367

Review 3.  Proteomics and transcriptomics in atrial fibrillation.

Authors:  Marc Sühling; Carmen Wolke; Christian Scharf; Uwe Lendeckel
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2018-01-09

4.  Chronic heart failure and the substrate for atrial fibrillation.

Authors:  Arun Sridhar; Yoshinori Nishijima; Dmitry Terentyev; Mahmood Khan; Radmila Terentyeva; Robert L Hamlin; Tomohiro Nakayama; Sandor Gyorke; Arturo J Cardounel; Cynthia A Carnes
Journal:  Cardiovasc Res       Date:  2009-06-30       Impact factor: 10.787

5.  Protective regulation of the ACE2/ACE gene expression by estrogen in human atrial tissue from elderly men.

Authors:  A Bukowska; L Spiller; C Wolke; U Lendeckel; S Weinert; J Hoffmann; P Bornfleth; I Kutschka; A Gardemann; B Isermann; A Goette
Journal:  Exp Biol Med (Maywood)       Date:  2017-06-29

Review 6.  Atrial thrombogenesis in atrial fibrillation : Results from atrial fibrillation models and AF-patients.

Authors:  Alicja Bukowska; Matthias Hammwöhner; Domenico Corradi; Wisno Mahardhika; Andreas Goette
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2017-12-12

Review 7.  Perspectives and challenges of antioxidant therapy for atrial fibrillation.

Authors:  Iveta Gasparova; Peter Kubatka; Radka Opatrilova; Martin Caprnda; Slavomira Filipova; Luis Rodrigo; Leone Malan; Ioana Mozos; Miroslava Rabajdova; Vladimir Nosal; Nazarii Kobyliak; Vanda Valentova; Daniel Petrovic; Mariusz Adamek; Peter Kruzliak
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-11-29       Impact factor: 3.000

8.  Tetrahydrobiopterin depletion and NOS2 uncoupling contribute to heart failure-induced alterations in atrial electrophysiology.

Authors:  Yoshinori Nishijima; Arun Sridhar; Ingrid Bonilla; Murugesan Velayutham; Mahmood Khan; Radmila Terentyeva; Chun Li; Periannan Kuppusamy; Terry S Elton; Dmitry Terentyev; Sandor Györke; Jay L Zweier; Arturo J Cardounel; Cynthia A Carnes
Journal:  Cardiovasc Res       Date:  2011-04-01       Impact factor: 10.787

9.  Selective downregulation of mitochondrial electron transport chain activity and increased oxidative stress in human atrial fibrillation.

Authors:  Larisa Emelyanova; Zain Ashary; Milanka Cosic; Ulugbek Negmadjanov; Gracious Ross; Farhan Rizvi; Susan Olet; David Kress; Jasbir Sra; A Jamil Tajik; Ekhson L Holmuhamedov; Yang Shi; Arshad Jahangir
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-05-06       Impact factor: 4.733

Review 10.  Atrial Calpains: Mediators of Atrialmyopathies in Atrial Fibrillation.

Authors:  Alicja Bukowska; Uwe Lendeckel; Andreas Goette
Journal:  J Atr Fibrillation       Date:  2014-04-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.